Placenta Protein Profiling Reveals A Landscape of Immune Signaling in COVID-19 Pregnant Woman

Cao yuming,Chen zhenlie,Chen huijun,Guo juanjuan,Yu xuechen,Zhang yuanzhen
2021-01-01
Abstract:Effective detection and treatment of COVID-19 is still a major challenge. However, a comprehensive and detailed description of the changes experienced by human placental immune cells after COVID-19 infection is still lacking. Here, we performed proteomic profiling of placenta from 5 Nucleic acid positive COVID-19 pregnant women and 5 control individuals. The 162 proteins showed differential expression in COVID-19 pregnant women, of which 108 were up-regulated and 54 were down regulated. The difference of serum immune indexes between 19 pregnant women diagnosed with COVID-19 infection and 17 controls was analyzed. We found that changes in immune cells were associated with an increased risk of infection. We found that with the infection of COVID-19, the immune cell landscape was reprogrammed, characterized by increased number of late natural killer cells. Notably, the prenatal NK cell count of pregnant women diagnosed with COVID-19 infection was significantly higher than that of the control group (P=0.009). Therefore, these findings suggest that immune system disorders associated with susceptibility to SARS-COV-2 may at least partially explain the vulnerability of COVID-19.
What problem does this paper attempt to address?